Indiana Seed Funds
BioCrossroads has established two early-stage life sciences venture funds focused on identifying, creating and developing the next generation of leading lndiana-based companies – the $6 million Indiana Seed Fund I (2005) and the $8 million Indiana Seed Fund II (2012). Managed by BioCrossroads, the Funds make investments in early-stage biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech and health information technology products and platforms and will continue to focus on forming promising companies around innovative ideas. To be considered for investment, companies are expected to have proven management teams, owned or licensed technology, intellectual property, and be able to demonstrate a validated market need. Ideal companies will be progressing towards defined milestones to secure a Series A financing, strategic partnership or co-development agreement.